Inhibition of spontaneous and experimental lung metastasis of soft-tissue sarcoma by tumor-targeting Salmonella typhimurium A1-R

Shinji Miwa, Yong Zhang, Kyung Eun Baek, Fuminari Uehara, Shuuya Yano, Mako Yamamoto, Yukihiko Hiroshima, Yasunori Matsumoto, Hiroaki Kimura, Katsuhiro Hayashi, Norio Yamamoto, Michael Bouvet, Hiroyuki Tsuchiya, Robert M. Hoffman, Ming Zhao

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Prognosis of patients with lung metastases of soft-tissue sarcoma is still poor. Therefore, novel systemic therapy is needed to improve the survival of soft-tissue sarcoma. In the present study, tumor-targeting therapy with a genetically-modified auxotrophic strain of Salmonella typhimurium, termed A1-R, was evaluated. Mouse models of primary soft tissue sarcoma and spontaneous lung metastasis were obtained by orthotopic intra-muscular injection of HT1080-RFP human fibrosarcoma cells. S. typhimurium A1-R was administered from day 14, once a week for two weeks. On day 28, lung samples were excised and observed with a fluorescence imaging system. The number of lung metastasis was 8.8 ± 3.4 in the untreated group and 0.8 ± 0.8 in the treated group (P = 0.024). A mouse model of experimental lung metastasis was obtained by tail vein injection of HT1080-RFP cells. The mice were treated with S. typhimurium A1-R (i.v.) on day 7, once a week for three weeks. S. typhimurium A1-R significantly reduced lung metastases and improved overall survival (P = 0.004). S. typhimurium A1-R bacterial therapy has future potential for treating advanced soft tissue sarcoma and improving prognosis of patients with lung metastasis.

Original languageEnglish
Pages (from-to)12849-12861
Number of pages13
JournalOncotarget
Volume5
Issue number24
DOIs
Publication statusPublished - Jan 1 2014
Externally publishedYes

Fingerprint

Salmonella typhimurium
Sarcoma
Neoplasm Metastasis
Lung
Neoplasms
Injections
Survival
Fibrosarcoma
Optical Imaging
Tail
Veins
Theoretical Models
Therapeutics

Keywords

  • Bacterial therapy
  • HT-1080
  • Lung metastasis
  • Nude mice
  • Orthotopic model

ASJC Scopus subject areas

  • Oncology

Cite this

Inhibition of spontaneous and experimental lung metastasis of soft-tissue sarcoma by tumor-targeting Salmonella typhimurium A1-R. / Miwa, Shinji; Zhang, Yong; Baek, Kyung Eun; Uehara, Fuminari; Yano, Shuuya; Yamamoto, Mako; Hiroshima, Yukihiko; Matsumoto, Yasunori; Kimura, Hiroaki; Hayashi, Katsuhiro; Yamamoto, Norio; Bouvet, Michael; Tsuchiya, Hiroyuki; Hoffman, Robert M.; Zhao, Ming.

In: Oncotarget, Vol. 5, No. 24, 01.01.2014, p. 12849-12861.

Research output: Contribution to journalArticle

Miwa, S, Zhang, Y, Baek, KE, Uehara, F, Yano, S, Yamamoto, M, Hiroshima, Y, Matsumoto, Y, Kimura, H, Hayashi, K, Yamamoto, N, Bouvet, M, Tsuchiya, H, Hoffman, RM & Zhao, M 2014, 'Inhibition of spontaneous and experimental lung metastasis of soft-tissue sarcoma by tumor-targeting Salmonella typhimurium A1-R', Oncotarget, vol. 5, no. 24, pp. 12849-12861. https://doi.org/10.18632/oncotarget.2561
Miwa, Shinji ; Zhang, Yong ; Baek, Kyung Eun ; Uehara, Fuminari ; Yano, Shuuya ; Yamamoto, Mako ; Hiroshima, Yukihiko ; Matsumoto, Yasunori ; Kimura, Hiroaki ; Hayashi, Katsuhiro ; Yamamoto, Norio ; Bouvet, Michael ; Tsuchiya, Hiroyuki ; Hoffman, Robert M. ; Zhao, Ming. / Inhibition of spontaneous and experimental lung metastasis of soft-tissue sarcoma by tumor-targeting Salmonella typhimurium A1-R. In: Oncotarget. 2014 ; Vol. 5, No. 24. pp. 12849-12861.
@article{538a2ffeae634bdeb7c22a0b2e8edaa2,
title = "Inhibition of spontaneous and experimental lung metastasis of soft-tissue sarcoma by tumor-targeting Salmonella typhimurium A1-R",
abstract = "Prognosis of patients with lung metastases of soft-tissue sarcoma is still poor. Therefore, novel systemic therapy is needed to improve the survival of soft-tissue sarcoma. In the present study, tumor-targeting therapy with a genetically-modified auxotrophic strain of Salmonella typhimurium, termed A1-R, was evaluated. Mouse models of primary soft tissue sarcoma and spontaneous lung metastasis were obtained by orthotopic intra-muscular injection of HT1080-RFP human fibrosarcoma cells. S. typhimurium A1-R was administered from day 14, once a week for two weeks. On day 28, lung samples were excised and observed with a fluorescence imaging system. The number of lung metastasis was 8.8 ± 3.4 in the untreated group and 0.8 ± 0.8 in the treated group (P = 0.024). A mouse model of experimental lung metastasis was obtained by tail vein injection of HT1080-RFP cells. The mice were treated with S. typhimurium A1-R (i.v.) on day 7, once a week for three weeks. S. typhimurium A1-R significantly reduced lung metastases and improved overall survival (P = 0.004). S. typhimurium A1-R bacterial therapy has future potential for treating advanced soft tissue sarcoma and improving prognosis of patients with lung metastasis.",
keywords = "Bacterial therapy, HT-1080, Lung metastasis, Nude mice, Orthotopic model",
author = "Shinji Miwa and Yong Zhang and Baek, {Kyung Eun} and Fuminari Uehara and Shuuya Yano and Mako Yamamoto and Yukihiko Hiroshima and Yasunori Matsumoto and Hiroaki Kimura and Katsuhiro Hayashi and Norio Yamamoto and Michael Bouvet and Hiroyuki Tsuchiya and Hoffman, {Robert M.} and Ming Zhao",
year = "2014",
month = "1",
day = "1",
doi = "10.18632/oncotarget.2561",
language = "English",
volume = "5",
pages = "12849--12861",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "24",

}

TY - JOUR

T1 - Inhibition of spontaneous and experimental lung metastasis of soft-tissue sarcoma by tumor-targeting Salmonella typhimurium A1-R

AU - Miwa, Shinji

AU - Zhang, Yong

AU - Baek, Kyung Eun

AU - Uehara, Fuminari

AU - Yano, Shuuya

AU - Yamamoto, Mako

AU - Hiroshima, Yukihiko

AU - Matsumoto, Yasunori

AU - Kimura, Hiroaki

AU - Hayashi, Katsuhiro

AU - Yamamoto, Norio

AU - Bouvet, Michael

AU - Tsuchiya, Hiroyuki

AU - Hoffman, Robert M.

AU - Zhao, Ming

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Prognosis of patients with lung metastases of soft-tissue sarcoma is still poor. Therefore, novel systemic therapy is needed to improve the survival of soft-tissue sarcoma. In the present study, tumor-targeting therapy with a genetically-modified auxotrophic strain of Salmonella typhimurium, termed A1-R, was evaluated. Mouse models of primary soft tissue sarcoma and spontaneous lung metastasis were obtained by orthotopic intra-muscular injection of HT1080-RFP human fibrosarcoma cells. S. typhimurium A1-R was administered from day 14, once a week for two weeks. On day 28, lung samples were excised and observed with a fluorescence imaging system. The number of lung metastasis was 8.8 ± 3.4 in the untreated group and 0.8 ± 0.8 in the treated group (P = 0.024). A mouse model of experimental lung metastasis was obtained by tail vein injection of HT1080-RFP cells. The mice were treated with S. typhimurium A1-R (i.v.) on day 7, once a week for three weeks. S. typhimurium A1-R significantly reduced lung metastases and improved overall survival (P = 0.004). S. typhimurium A1-R bacterial therapy has future potential for treating advanced soft tissue sarcoma and improving prognosis of patients with lung metastasis.

AB - Prognosis of patients with lung metastases of soft-tissue sarcoma is still poor. Therefore, novel systemic therapy is needed to improve the survival of soft-tissue sarcoma. In the present study, tumor-targeting therapy with a genetically-modified auxotrophic strain of Salmonella typhimurium, termed A1-R, was evaluated. Mouse models of primary soft tissue sarcoma and spontaneous lung metastasis were obtained by orthotopic intra-muscular injection of HT1080-RFP human fibrosarcoma cells. S. typhimurium A1-R was administered from day 14, once a week for two weeks. On day 28, lung samples were excised and observed with a fluorescence imaging system. The number of lung metastasis was 8.8 ± 3.4 in the untreated group and 0.8 ± 0.8 in the treated group (P = 0.024). A mouse model of experimental lung metastasis was obtained by tail vein injection of HT1080-RFP cells. The mice were treated with S. typhimurium A1-R (i.v.) on day 7, once a week for three weeks. S. typhimurium A1-R significantly reduced lung metastases and improved overall survival (P = 0.004). S. typhimurium A1-R bacterial therapy has future potential for treating advanced soft tissue sarcoma and improving prognosis of patients with lung metastasis.

KW - Bacterial therapy

KW - HT-1080

KW - Lung metastasis

KW - Nude mice

KW - Orthotopic model

UR - http://www.scopus.com/inward/record.url?scp=84921368290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921368290&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.2561

DO - 10.18632/oncotarget.2561

M3 - Article

VL - 5

SP - 12849

EP - 12861

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 24

ER -